| Drug Name | Hemlibra (emicizumab) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
Thromboembolism, thrombotic microangiopathy and laboratory coagulation test interference |
| Patient card |
|
| Health care provider guide |
|